Oxford begins first human trial of Bundibugyo Ebola vaccine
8 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
The obvious questions
Why is "Oxford begins first human trial of Bundibugyo Ebola vaccine" trending?
Because 8 independent news sources published 9 articles about it in a short window — a coverage burst Newsylist classifies as a trend.
How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
🌍 Language by language
This story first appeared in 🇧🇷 Portuguese coverage — 8.5 hours before Newsylist detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
The story so far
- Velocity & Diffusion: Coverage escalated across 8 distinct news outlets with 9 published articles, achieving a live velocity of 6.
- Primary Driver: 8 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Oxford begins first human trial of Bundibugyo Ebola vaccine" is generating significant coverage in the Health category, with 9 articles from 8 distinct sources tracked by Newsylist so far.
Outlets currently covering the story include The Seattle Times, Bloomberg.com, The Telegraph and University of Oxford. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized under Newsylist open intelligence methodology from multi-source international newsroom telemetry. Updated 60d ago.
Coverage (9)
-
-
-
-
-
-
-
-
-
Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 63d ago broke it first
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
DR Congo Ebola epidemic becomes world’s second largest outbreak
4 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Congo’s Ebola death toll passes 1,500 as it struggles to halt spread
4 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Death toll tops 1,500 in fastest-growing Ebola outbreak in history, Congo says
4 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Ebola cases in Congo top 3,200, nearing record of the country’s worst outbreak
9 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Uganda declares end to Ebola outbreak
7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
A day in the life of Congo's overstretched Ebola surveillance teams
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.